Lutetium [ 177 Lu]-DOTA-TATE in gastroenteropancreatic-neuroendocrine tumours: rationale, design and baseline characteristics of the Italian prospective observational (REAL-LU) study.
Secondo LastoriaMarcello RodariMaddalena SansoviniSergio BaldariAntonio D'AgostiniAnna Rita CervinoAngelina FiliceMatteo SalgarelloGermano PerottiAlberto NieriDavide CampanaRiccardo Emanuele PelleritoElena PomposelliValeria GaudieriGiovanni StortoChiara Maria GranaAlberto SignoreGiuseppe BoniFrancesco DondiGabriele SimontacchiEttore SeregniPublished in: European journal of nuclear medicine and molecular imaging (2024)
ClinicalTrials.gov, NCT04727723; Study Registration Date: 25 January, 2021; https://clinicaltrials.gov/study/NCT04727723?cond=NCT04727723&rank=1.